JP2012523009A5 - - Google Patents

Download PDF

Info

Publication number
JP2012523009A5
JP2012523009A5 JP2012504782A JP2012504782A JP2012523009A5 JP 2012523009 A5 JP2012523009 A5 JP 2012523009A5 JP 2012504782 A JP2012504782 A JP 2012504782A JP 2012504782 A JP2012504782 A JP 2012504782A JP 2012523009 A5 JP2012523009 A5 JP 2012523009A5
Authority
JP
Japan
Prior art keywords
markers
score
mammal
present
disease score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012504782A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012523009A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/030104 external-priority patent/WO2010118035A2/en
Publication of JP2012523009A publication Critical patent/JP2012523009A/ja
Publication of JP2012523009A5 publication Critical patent/JP2012523009A5/ja
Pending legal-status Critical Current

Links

JP2012504782A 2009-04-06 2010-04-06 精神神経疾患の治療をモニタリングするためのバイオマーカー Pending JP2012523009A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16698609P 2009-04-06 2009-04-06
US61/166,986 2009-04-06
PCT/US2010/030104 WO2010118035A2 (en) 2009-04-06 2010-04-06 Biomarkers for monitoring treatment of neuropsychiatric diseases

Publications (2)

Publication Number Publication Date
JP2012523009A JP2012523009A (ja) 2012-09-27
JP2012523009A5 true JP2012523009A5 (cg-RX-API-DMAC7.html) 2013-05-23

Family

ID=42936849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012504782A Pending JP2012523009A (ja) 2009-04-06 2010-04-06 精神神経疾患の治療をモニタリングするためのバイオマーカー

Country Status (6)

Country Link
US (1) US20100280562A1 (cg-RX-API-DMAC7.html)
EP (1) EP2417448A4 (cg-RX-API-DMAC7.html)
JP (1) JP2012523009A (cg-RX-API-DMAC7.html)
CN (1) CN102460153A (cg-RX-API-DMAC7.html)
CA (1) CA2757659A1 (cg-RX-API-DMAC7.html)
WO (1) WO2010118035A2 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
US8868177B2 (en) * 2009-03-20 2014-10-21 ElectroCore, LLC Non-invasive treatment of neurodegenerative diseases
US8158374B1 (en) 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
EP2337866B1 (en) * 2008-10-15 2014-07-30 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
EP2356453A4 (en) * 2008-11-18 2012-08-15 Ridge Diagnostics Inc METABOLISM SYNDROME AND HPA AXIS BIOMARKERS FOR HEAVY DEPRESSION
EP2414824B1 (en) * 2009-04-01 2017-12-06 Vindrauga Holdings, LLC Biomarkers for monitoring treatment of neuropsychiatric diseases
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
EP2440284B1 (en) 2009-06-09 2018-09-12 Setpoint Medical Corporation Nerve cuff with pocket for leadless stimulator
WO2014169145A1 (en) 2013-04-10 2014-10-16 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
EP2515996B1 (en) 2009-12-23 2019-09-18 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
EP2529222A4 (en) * 2010-01-26 2013-10-09 Ridge Diagnostics Inc MULTIPLE BIOMARKER PANELS FOR STRATIFYING ILLNESS HEAVY GRADES AND MONITORING THE TREATMENT OF DEPRESSIONS
WO2012081701A1 (ja) 2010-12-16 2012-06-21 独立行政法人産業技術総合研究所 髄液型糖タンパク質の富化及び分離方法、並びにその方法を用いた中枢神経系疾患用マーカーの探索方法及び中枢神経系疾患用マーカー
US20120238837A1 (en) * 2011-03-16 2012-09-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System, devices, and methods for real-time monitoring of cerebrospinal fluid for markers of progressive conditions
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US8737709B2 (en) * 2012-04-30 2014-05-27 General Electric Company Systems and methods for performing correlation analysis on clinical outcome and characteristics of biological tissue
EP3022560B1 (en) 2013-07-11 2020-09-02 University of North Texas Health Science Center at Fort Worth Blood-based screen for detecting neurological diseases in primary care settings
CA2930874A1 (en) * 2013-11-26 2015-06-04 University Of North Texas Health Science Center At Fort Worth Personalized medicine approach for treating cognitive loss
WO2015127476A1 (en) * 2014-02-24 2015-08-27 Setpoint Medial Corporation Vagus nerve stimulation screening test
US20170161441A1 (en) * 2014-07-02 2017-06-08 Ridge Diagnostics, Inc. Methods and materials for treating pain and depression
WO2016033543A1 (en) * 2014-08-28 2016-03-03 Medtronic Ardian Luxembourg S.A.R.L. Methods for assessing efficacy of renal neuromodulation and associated systems and devices
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US11406833B2 (en) 2015-02-03 2022-08-09 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
EP3405255B1 (en) 2016-01-20 2025-12-31 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION CHARGING SYSTEMS
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
US10695569B2 (en) 2016-01-20 2020-06-30 Setpoint Medical Corporation Control of vagal stimulation
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11045126B2 (en) 2016-10-28 2021-06-29 Koa Health B.V. System and a method for enabling responsive cognitive behavioral therapy
EP3612083B8 (en) 2017-04-20 2022-12-28 The Feinstein Institutes for Medical Research Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND MONITORING OF TREATMENT
WO2019143562A1 (en) * 2018-01-18 2019-07-25 University Of North Texas Health Science Center At Fort Worth Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
CN113939334A (zh) 2019-04-12 2022-01-14 赛博恩特医疗器械公司 迷走神经刺激来处理神经退行性障碍
CN111524596A (zh) * 2020-04-07 2020-08-11 上海市精神卫生中心（上海市心理咨询培训中心） 一种判断青少年双相障碍发病风险的方法
IL298193B2 (en) 2020-05-21 2024-01-01 Feinstein Institutes For Medical Research Systems and methods for vagus nerve stimulation
WO2022245878A1 (en) 2021-05-17 2022-11-24 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) * 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5882203A (en) * 1995-05-31 1999-03-16 Correa; Elsa I. Method of detecting depression
US5658802A (en) * 1995-09-07 1997-08-19 Microfab Technologies, Inc. Method and apparatus for making miniaturized diagnostic arrays
US5804453A (en) * 1996-02-09 1998-09-08 Duan-Jun Chen Fiber optic direct-sensing bioprobe using a phase-tracking approach
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20030032200A1 (en) * 2000-02-24 2003-02-13 Herath Herath Mudiyanselage Athula Chandrasiri Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression
US20040110938A1 (en) * 2000-02-24 2004-06-10 Parekh Rajesh Bhikhu Proteins, genes and their use for diagnosis and treatment of schizophrenia
US7041206B2 (en) * 2000-03-09 2006-05-09 Clinical Analysis Corporation Medical diagnostic system
US7118710B2 (en) * 2000-10-30 2006-10-10 Sru Biosystems, Inc. Label-free high-throughput optical technique for detecting biomolecular interactions
US6905816B2 (en) * 2000-11-27 2005-06-14 Intelligent Medical Devices, Inc. Clinically intelligent diagnostic devices and methods
WO2002089657A2 (en) * 2001-05-04 2002-11-14 Biosite, Inc. Diagnostic markers of acute coronary syndromes and methods of use thereof
US6710877B2 (en) * 2001-07-23 2004-03-23 Corning Incorporated Apparatus and methods for determining biomolecular interactions
WO2003043487A2 (en) * 2001-11-19 2003-05-30 Protometrix, Inc. Method of using a non-antibody protein to detect and measure an analyte
US7136518B2 (en) * 2003-04-18 2006-11-14 Medispectra, Inc. Methods and apparatus for displaying diagnostic data
US20040152107A1 (en) * 2002-09-18 2004-08-05 C. Anthony Altar Gene signature of electroshock therapy and methods of use
KR20040032451A (ko) * 2002-10-09 2004-04-17 삼성전자주식회사 생체신호 기반의 건강 관리 기능을 갖는 모바일 기기 및이를 이용한 건강 관리 방법
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
AU2004238259B2 (en) * 2003-05-06 2010-02-18 Covidien Lp System and method of assessment of the efficacy of treatment of neurological disorders using the electroencephalogram
US7706871B2 (en) * 2003-05-06 2010-04-27 Nellcor Puritan Bennett Llc System and method of prediction of response to neurological treatment using the electroencephalogram
US20040228765A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20040228766A1 (en) * 2003-05-14 2004-11-18 Witty Thomas R. Point of care diagnostic platform
US20050084880A1 (en) * 2003-07-11 2005-04-21 Ronald Duman Systems and methods for diagnosing & treating psychological and behavioral conditions
US20070092888A1 (en) * 2003-09-23 2007-04-26 Cornelius Diamond Diagnostic markers of hypertension and methods of use thereof
US20050069936A1 (en) * 2003-09-26 2005-03-31 Cornelius Diamond Diagnostic markers of depression treatment and methods of use thereof
US7394547B2 (en) * 2003-11-06 2008-07-01 Fortebio, Inc. Fiber-optic assay apparatus based on phase-shift interferometry
JP2005312435A (ja) * 2004-03-29 2005-11-10 Kazuhito Rokutan うつ病の評価方法
US20050254065A1 (en) * 2004-05-12 2005-11-17 Stokowski Stanley E Method and apparatus for detecting surface characteristics on a mask blank
WO2006001749A1 (en) * 2004-06-24 2006-01-05 Biacore Ab Method for detecting molecular surface interactions
US20060063199A1 (en) * 2004-09-21 2006-03-23 Elgebaly Salwa A Diagnostic marker
US7445887B2 (en) * 2005-01-07 2008-11-04 Fortebio, Inc. Enzyme activity measurements using bio-layer interferometry
JP2007024822A (ja) * 2005-07-21 2007-02-01 Aska Pharmaceutical Co Ltd 男性の更年期又はうつ病の鑑別方法
WO2007045865A2 (en) * 2005-10-18 2007-04-26 Cambridge Enterprise Limited Methods and biomarkers for diagnosing and monitoring psychotic disorders such as schizophrenia
US20070161042A1 (en) * 2006-01-11 2007-07-12 Fortebio, Inc. Methods for characterizing molecular interactions
BRPI0707958B8 (pt) * 2006-02-17 2021-07-27 Sekiyama Atsuo composição e kit para testar condições mentais por uma análise de regressão logística e método de medição de condições mentais
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
US7651836B2 (en) * 2006-08-04 2010-01-26 Hospital Santiago Apóstol Methods for diagnosis and prognostic of psychiatric diseases
US8158374B1 (en) * 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US20080199866A1 (en) * 2006-10-10 2008-08-21 The Board Of Trustees Of The Leland Stanford Junior University Snp detection and other methods for characterizing and treating bipolar disorder and other ailments
US8518651B2 (en) * 2007-02-16 2013-08-27 Shimadzu Corporation Marker for identification of tissue type of epithelial ovarian cancer, and method for determination of the occurrence of epithelial ovarian cancer based on tissue type by using the marker
US20080281531A1 (en) * 2007-03-15 2008-11-13 Kazuhito Rokutan Method for Diagnosing Depression
CA2717763A1 (en) * 2008-03-04 2009-09-11 John Bilello Diagnosing and monitoring depression disorders based on multiple biomarker panels
JP5658571B2 (ja) * 2008-03-12 2015-01-28 リッジ ダイアグノスティックス，インコーポレイテッド うつ障害をモニタリングするための炎症バイオマーカー
EP2337866B1 (en) * 2008-10-15 2014-07-30 Ridge Diagnostics, Inc. Human biomarker hypermapping for depressive disorders
EP2356453A4 (en) * 2008-11-18 2012-08-15 Ridge Diagnostics Inc METABOLISM SYNDROME AND HPA AXIS BIOMARKERS FOR HEAVY DEPRESSION
EP2414824B1 (en) * 2009-04-01 2017-12-06 Vindrauga Holdings, LLC Biomarkers for monitoring treatment of neuropsychiatric diseases
EP2529222A4 (en) * 2010-01-26 2013-10-09 Ridge Diagnostics Inc MULTIPLE BIOMARKER PANELS FOR STRATIFYING ILLNESS HEAVY GRADES AND MONITORING THE TREATMENT OF DEPRESSIONS
CN103370624A (zh) * 2010-12-06 2013-10-23 里奇诊断学股份有限公司 监控神经精神疾病治疗的生物标记

Similar Documents

Publication Publication Date Title
JP2012523009A5 (cg-RX-API-DMAC7.html)
JP2012522995A5 (cg-RX-API-DMAC7.html)
Klyucherev et al. Advances in the development of new biomarkers for Alzheimer’s disease
Zhang et al. Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation
Gittins et al. A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder
Maestri et al. Non-rapid eye movement sleep instability in mild cognitive impairment: a pilot study
US20170023591A1 (en) Traumatic Brain Injury and Neurodegenerative Biomarkers, Methods, and Systems
EP3134552B1 (en) Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers
Segura et al. Neurotrophin blood-based gene expression and social cognition analysis in patients with autism spectrum disorder
Sylvestre et al. Untargeted metabolomic analysis of plasma from relapsing-remitting multiple sclerosis patients reveals changes in metabolites associated with structural changes in brain
WO2020125530A1 (zh) D-丝氨酸作为标志物在制备抑郁症诊断试剂盒中的应用及抑郁症诊断试剂盒
Mayeli et al. Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of schizophrenia spectrum disorder patients
Zhou et al. Correlation between plasma CircRNA-089763 and postoperative cognitive dysfunction in elderly patients undergoing non-cardiac surgery
Myhr et al. The N orwegian M ultiple S clerosis R egistry and B iobank
Walker et al. Study protocol for teen inflammation glutamate emotion research (TIGER)
Lal et al. Proteomic biomarkers of cognitive impairment in obstructive sleep apnea syndrome
Wei et al. Differential neuropsychiatric associations of plasma biomarkers in older adults with major depression and subjective cognitive decline
Chan Early diagnosis, monitoring, and treatment of optic neuritis
WO2024074133A1 (en) Protein marker for assessing and treating neurodegenerative diseases
Galkin et al. Electroencephalogram Coherence and Peripheral Markers of Nervous Tissue Damage in Depressive Disorders
Dadsena et al. Evidence of clinical and brain recovery in post-COVID-19 condition: a three-year follow-up study
KR102184840B1 (ko) 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도
Penner Effects of Interval Exercise on Commonly Studied Fluid Biomarkers for Sport-related Concussion in Serum and Plasma
Alarcan et al. Theme 10-Disease Stratification and Phenotyping of Patients.
Balashov et al. Increased expression of miR-130b-5p in B cells and its modulation by glatiramer acetate in multiple sclerosis